TGFB1 and COVID-19: Therefore, nanoceria can be used as a novel therapeutic material for the management of COVID-19 through either direct virus inactivation on surfaces or administration in the body, interrupting the progression of systemic inflammatory complications due to its ability to inhibit NFkB, MAPKs, and TGF-β signaling pathways24⁠.